Kyrgios and the doping case: When the 'anti-doping crusader' becomes the 'exposed one'

During the opening week of the 2026 US Open, Nick Kyrgios did not step onto the court for a single match, yet he was the most talked-about name in world tennis forums. The reason was not a beautiful shot, but a piece of paper from the ITIA: his sample from the Mallorca tournament in late June tested positive for benzoylecgonine – a cocaine metabolite. The announcement came on August 19, while the season's final Grand Slam was underway, and the provisional suspension had been in effect since August 4. Data is never in a hurry. Those who rush are the ones who are wrong. But this time, even the numbers had to pause to look at a career collapsing right before our eyes. Kyrgios, 31, has never won a singles Grand Slam. His best result was the 2026 Wimbledon final, where he lost to Novak Djokovic in four sets. That same year, he won the Australian Open doubles title and reached the US Open quarterfinals, losing to Karen Khachanov in five sets. That was the peak of his career, achieved at age 27. Three years later, with a history of wrist and knee injuries, he had virtually disappeared from the tour. His career was already in decline before this doping case emerged. But what makes this case particularly striking is not the banned substance itself, but the collapse of an image he had carefully constructed over many years. Before his own positive test, Kyrgios was one of the loudest voices condemning doping in tennis. He called Jannik Sinner a 'cheat' after the clostebol case, mocked Iga Swiatek when she tested positive for trimetazidine, and particularly attacked Simona Halep when she was found to have roxadustat. He once said Halep 'should be banned forever' and that she 'did not deserve to compete.' Those statements were posted publicly on social media, even when he was not playing. Now that he himself has tested positive for a stimulant, those criticisms have come back to haunt him like a curse. Andy Roddick, on his podcast, called Kyrgios's behavior 'pure hypocrisy' and referenced Kyrgios's guilty plea for assaulting his girlfriend – a detail the original article does not directly mention but Roddick quoted. The reaction from fellow players is also notable. Stefanos Tsitsipas, who has had many conflicts with Kyrgios, spoke out in his post-match press conference at the US Open, saying 'tennis needs clean role models.' Karen Khachanov, who beat Kyrgios in the 2026 US Open quarterfinals, wrote on social media: 'You reap what you sow.' All three players – Tsitsipas, Roddick, Khachanov – have not rushed to Kyrgios's defense. This shows the degree of isolation he faces in the professional tennis world. In a sport where players typically avoid publicly criticizing their peers, having three players from different generations speak out is a very strong signal. Technically, benzoylecgonine is a metabolite of cocaine, a stimulant prohibited in competition under WADA rules. However, cocaine is classified as a 'Specified Substance' – meaning sanctions can be reduced if the player proves the use was not intended to enhance performance. This is the key point in Kyrgios's case. If he can prove he used cocaine out of competition, for recreational purposes, and not to improve results, the sanction could be significantly reduced. The Halep precedent is a clear example: she was banned for four years, but after appealing to CAS, the ban was reduced to nine months. However, Kyrgios's previous public attacks on Halep will make it extremely awkward for him to invoke this precedent. Data on Kyrgios's recent form is almost non-existent. He has no significant match statistics since 2026. This reveals a harsh truth: his career had been declining long before this doping case. At 31, with a dense injury history, and now a suspension that could last months or years, the likelihood of him returning to the top 20 is extremely low. People remember results. I remember the conditions that shape results. And Kyrgios's current conditions – age, injuries, suspension, and isolation from peers – all point in one direction: the end of a career full of potential but never realized. Interestingly, Kyrgios's case comes amid a credibility crisis in tennis regarding doping. Sinner is still allowed to compete while his clostebol case is under investigation, Swiatek received a one-month suspension, Halep returned after her ban was reduced. Now Kyrgios. Four major cases in two years, each handled differently. This raises questions about the consistency of ITIA's anti-doping enforcement. Why is Sinner allowed to compete while Kyrgios is suspended immediately? Is it because Sinner is world No. 1, while Kyrgios is just a declining player? Data is never in a hurry, but the difference in handling between cases could set a dangerous precedent. Another counterintuitive angle: this doping case may not be Kyrgios's biggest problem. His biggest problem is the collapse of the 'anti-doping crusader' image he built over years. Previously, he was known as a talented but erratic player who always created controversy on court. After this case, he becomes a symbol of hypocrisy. Roddick said it well: 'He spent years condemning others, and now he has done the same thing.' Kyrgios's career may have ended long ago, but this doping case has completely buried any chance he had to rebuild his reputation. Tactically, the fact that the sample was taken at the Mallorca tournament – an ATP 250 on grass, held in late June, just before Wimbledon – suggests Kyrgios was planning a return at Wimbledon. This was a sensible tactical decision: grass is the surface best suited to his serve-and-forehand game. But this very small tournament became the place where his career ended. The irony cannot be expressed in words. Spectators may leave the court, but physical data never rests. And Kyrgios's physical data – with his injury history and age – already indicated he could no longer sustain his high-risk style of play. The biggest question now is not whether Kyrgios can return. The biggest question is whether ITIA is handling doping cases fairly. Sinner, who tested positive for clostebol – an anabolic agent – is still competing, while Kyrgios, who tested positive for cocaine – a recreational stimulant – was suspended immediately. This difference could be explained by Sinner proving he did not intentionally use the substance, while Kyrgios has not yet had the chance to present his case. But to the public, this creates a sense of injustice. Data is never in a hurry, but people are always quick to judge. Ultimately, Kyrgios's case is a lesson in humility. He spent years condemning others without looking at himself. He built a public image based on criticism, and now that image has completely collapsed. His career may be over, but his story will be remembered for years, as a warning about the dangers of hypocrisy. And when we look at the ATP rankings in the future, we will not see Nick Kyrgios's name there. But we will remember him, not for his great matches, but for a lesson about the collapse of trust.